Recommendations on diagnostics and treatment of sarcoidosis;Deutsche gesellschaft für pneumologie: Empfehlungen zur diagnostik und therapie der sarkoidose

Pneumologie

Volumn 52, Issue 1, 1998, Pages 26-30

  Barth, J ^a   Christ, R ^a   Costabel, U ^a   Dierkesmann, R ^a   Loddenkemper, R ^a   Muller Quernheim J ^a   Wiesner, B ^a   Worth, H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

CLASSIFICATION; GERMANY; HUMAN; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; SARCOIDOSIS;

GERMANY; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PRACTICE GUIDELINES; PROGNOSIS; SARCOIDOSIS; SARCOIDOSIS, PULMONARY;

EID: 33748060868     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Baughman, R. P., E. E. Lower: The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. Am. Rev. Respir. Dis. 142 (1990) 1268-1271
2. Böttger, D.: Sarkoidose. Theorie und Praxis. Johann Ambrosius Barth, Leipzig 1982
3. Concensus Conference: Activity of Sarcoidosis. Meeting report of 3rd WASOG meeting, USA, 1993. Eur. Respir. J. 7 (1994) 624-627
4. Costabel, U.: Atlas der bronchoalveolären Lavage. Thieme Verlag, Stuttgart 1994
5. DeRemee, R. A.: The roentgenolographic staging of sarcoidosis - historic and contemporary perspectives. Chest 83 (1983) 128-133
6. DeRemee, R. A.: Principles of treatment: Sarcoidosis. In: DeRemee, R. A.: Clinical profiles of diffuse interstitial pulmonary disease. (Futura Publishing Company: Mount Kisco, New York 1990) 141-148
7. Deutsche Gesellschaft für Pneumologie: Empfehlungen zum diagnostischen Vorgehen bei diffusen Lungenkrankheiten. Pneumologie 48 (suppl. 1) (1994) 281-286
8. duBois, R.: Diffuse lung disease: an approach to management. Brit. Med. J. 309 (1994) 175-179
9. Gibson, G. J., R. J. Prescott, M. F. Muers, W. G. Middleton, D. N. Mitchell, C. K. Condly, B. D. W. Harrison: British Thoracic Sarcoidosis Study: effects on long-term corticosteroid treatment. Thorax 51 (1996) 238-247
10. Harkleroad, L. E., R. L. Young, P. J. Savage, D. W. Jenkins, R. E. London: Pulmonary sarcoidosis: longterm follow-up of the effects of steroid therapy. Chest 82 (1982) 84-87
11. Hunninghake, G. W., S. Gilbert, R. Pueringer, C. Dayton, C. Floerchinger, R. Helmers, R. Merchant, J. Wilson, J. Calvin, D. Schwartz: Outcome of the treatment for sarcoidosis. Am. J. Respir. Crit. Care Med. 149 (1994) 893-898
12. Israel, H. L., D. W. Fouts, R. A. Beggs: A controlled trial of prednisone treatment of sarcoidosis. Am. Rev. Respir. Dis. 107 (1973) 609-614
13. James, D. G.: Epidemiology of sarcoidosis. Sarcoidosis 9 (suppl. 1) (1992) 3-4
14. Kirsten, D.: Herzsarkoidose. Pneumologie 48 (1994) 737-743
15. Kirsten, D.: Sarkoidose in Deutschland. Pneumologie 49 (1995) 378-382
16. Lower, E. E., R. P. Baughman: The use of low dose methotrexate of refractory sarcoidosis. Am. J. Med. Sci. 299 (1990) 153-157
17. Milman, N., N. graudal, G. Grode, E. Munch: No effect of high-dose inhaled steroids in pulmonary sarcoidosis: a double-blind, placebo-controlled study. J. Internal. Med. 236 (1994) 285-290
18. Müller-Quernheim, J., S. Pfeifer, J. Strausz, R. Ferlinz: Correlation of clinical and immunologic parameters of the inflammatory activity of pulmonary sarcoidosis. Am. Rev. Respir. Dis. 144 (1991) 1322-1399
19. Müller-Quernheim, J.: Klinische und immunbiologische Betrachtungen zur entzündlichen Aktivität der Sarkoidose. Pneumologie 50 (1996) 40-48
20. Pacheco, Y., C. Marechal, F. Marechal, N. Biot, M. Perrin Fayolle: Azathioprine treatment of chronic pulmonary sarcoidosis. Sarcoidosis 2 (1985) 107-113
21. Pia, G., L. Pascalis, G. Arescu, L. Rosetti, M. A. Ledda: Evaluation of the efficacy and toxicity of the cyclosporin A-fluocortolone methotrexate combination in the treatment of sarcoidosis. Sarcoidosis, Vasculitis and Diffuse Lung Disease 13 (1996) 146-152
22. Remy-Jardin, M., F. Giraud, J. Remy, L. Wattine, B. Wallaert, S. Duhamel: Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology 191 (1994) 675-680
23. Scharkoff, Th.: Epidemiologie der Sarkoidose. Pneumologie 47 (1993) 588-592
24. Selroos, O., T.-L Sellergren: Corticosteroid therapy of pulmonary sarcoidosis. Scand. J. Respir. Dis. 60 (1979) 215-221
25. Semenzato, G.: Assessment of disease activity in sarcoidosis - deeds and misdeeds. Sarcoidosis 10 (1993) 100-103
26. Sharma, O. P.: Pulmonary sarcoidosis and corticosteroids. Am. Rev. Respir. Dis. 147 (1993) 1598-1600
27. Thomas, P. D., G. W. Hunninghake: Current concepts of the pathogenesis of sarcoidosis. Am. Rev. Respir. Dis. 135 (1987) 747-760
28. Triebel, H.-J., G. Kanzow, M. Heller, H. Magnussen, E. Bücheler: Zur Bedeutung des Thorax-CT für die Diagnose der Lungensarkoidose. Fortschr. Röntgenstr. 153 (1990) 557-564
29. Vestbo, J., K. Viskum: Respiratory symptoms at presentation and long-term vital prognosis in patients with pulmonary sarcoidosis. Sarcoidosis 11 (1994) 123-125
30. Ward, K., C. O'Connor, C. Odlum, M. X. Fitzgerald: Prognostic value of bronchoalveolar lavage in sarcoidosis: The critical influence of disease presentation. Thorax 44 (1989) 6-12
31. Winterbauer, R. H., J. F. Hutchinson: Use of pulmonary function tests in the management of sarcoidosis. Chest 78 (1980) 640-647
32. Wurm, K.: Stadiengesetzlichkeit und Thoraxröntgenologie. In: Wurm, K. (Hrsg.): Sarkoidose. Thieme Verlag, Stuttgart, New York (1983) 75-105
33. Zaki, M. H., H. A. Lyons, L. Leilop, C. T. Huang: Corticosteroid therapy in sarcoidosis: a five-year, controlled follow-up study. N. Y. State J. Med. 87 (1987) 466-468